[
1. Zygogianni A, Kyrgias G, Mystakidou K, Antypas C, Kouvaris J, Papadimitriou C, et al. Potential role of the alcohol and smoking in the squamous cell carcinoma of the head and neck: review of the current literature and new perspectives. Asian Pac J Cancer Prev 2011; 12: 339-44.
]Search in Google Scholar
[
2. Krengli M, Policarpo M, Gambaro G, Panella M, Manfredda I, Alyffa P, et al. Voice quality after treatment for T1a glottic carcinoma - radiotherapy versus laser coredctomy. Acta Oncol 2004; 43: 284-9.10.1080/02841860410026233
]Search in Google Scholar
[
3. Goor KM, Peeters AJ, Mahieu HF, Langendijk JA, Leemans CR, Verdonck-de Leeuw IM, et al. Cordectomy by CO2 laser or radiotherapy for small T1a glottic carcinomas: costs, local control, survival, quality of life and voice quality. Head Neck 2007; 29: 128-36.10.1002/hed.20500
]Search in Google Scholar
[
4. Loughran S, Calder N, MacGregor FB, Carding P, MacKenzie K. Quality of life and voice following endoscopic resection or radiotherapy for early glottis cancer. Clin Otolaryngol 2005; 30: 42-7.10.1111/j.1365-2273.2004.00919.x
]Search in Google Scholar
[
5. Rhys-Evans P, Montgomery PQ, Gullane PJ. Principles and practice of head and neck oncology. London: Martin Dunitz; 2003.10.1201/9781482297119
]Search in Google Scholar
[
6. Kazi R, Venkitaran R, Johnson C, Prasad V, Clarke P, Newbold K, et al. Prospective, longitudinal electroglottographic study of voice recovery following accelerated hypofractionated radiotherapy for T1/T2 larynx cancer. Radiother Oncol 2008; 87: 230-6.10.1016/j.radonc.2008.01.006
]Search in Google Scholar
[
7. Plataniotis G, Kouvaris J, Hatzimichalis H, Papavasiliou CG, Vlachos L. Results of radiotherapy for T1 carcinoma of the glottis by fractions of 2.3 Gy per day. Acta Oncol 1997; 36; 342-3.10.3109/02841869709001275
]Search in Google Scholar
[
8. Marks LB, Yorke ED, Jackson A, Ten Haken RK, Constine LS, Eisbruch A, et al. Use of normal tissue complication probability models in the clinic. Int JRadiat Oncol Biol Phys 2010; 76(3 Suppl): S10-9.10.1016/j.ijrobp.2009.07.1754
]Search in Google Scholar
[
9. Fowler J. The linear quadratic formula and progress in fractionated radiotherapy. Br J Radiol 1989; 62: 679-94.10.1259/0007-1285-62-740-679
]Search in Google Scholar
[
10. Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol BiolPhys 1991; 21: 109-22.10.1016/0360-3016(91)90171-Y
]Search in Google Scholar
[
11. Thames HD, Bentzen SM, Turesson I, Overgaard M, Van den Bogaert W. Time-dose factors in radiotherapy: a review of the human data. RadiotherOncol 1990; 19: 219-35.10.1016/0167-8140(90)90149-Q
]Search in Google Scholar
[
12. Pesznyák C, Polgár I, Weisz C, Király R, Zaránd P. Verification of quality parameters for portal images in radiotherapy. Radiol Oncol 2011; 45: 68-74.10.2478/v10019-010-0052-6
]Search in Google Scholar
[
13. Zygogianni A, Kyrgias G, Kouvaris J, Antypas C, Theodorou K, Papageorgiou S, et al. Re-irradiation in head and neck cases using IMRT technique: a retrospective study with toxicity and survival report. Head Neck Oncol 2012; 4: 78.
]Search in Google Scholar
[
14. Gowda RV, Henk JM, Mais KL, Sykes AJ, Swindell R, Slevin NJ. Three weeks radiotherapy for T1 glottic cancer: the Christie and Royal Marsden Hospital experience. Radiother Oncol 2003; 68: 105-11.10.1016/S0167-8140(03)00059-8
]Search in Google Scholar
[
15. Short S, Krawitz H, Macann A, West T, Morton RP, McIvor NP, et al. T1N0/ T2N0 glottic carcinoma: a comparison of two fractionation schedules. AustrRad 2006; 50: 152-7.10.1111/j.1440-1673.2006.01559.x
]Search in Google Scholar
[
16. Dinshaw KA, Sharma V, Agarwal JP, Ghosh S, Havaldar R. Radiation therapy in T1-T2 glottic carcinoma: influence of various treatment parameters on local control/ complications. Int J Radiat Oncol Biol Phys 2000; 48: 723-35.10.1016/S0360-3016(00)00635-0
]Search in Google Scholar
[
17. Parsons JT, Greene BD, Speer TW, Kirkpatrick SA, Barhorst DB, Yanckowitz T. Treatment of early and moderately advanced vocal cord carcinoma with 6MV x-rays. Int J Radiat Oncol Biol Phys 2001; 50: 953-9.10.1016/S0360-3016(01)01472-9
]Search in Google Scholar
[
18. Skladowski K, Tarnawski R, Maciejewski B, Wygoda A, Slosarek K. Clinical radiobiology of glottis T1 squamous cell carcinoma. Int J Radiat Oncol BiolPhys 1999; 43: 101-6.10.1016/S0360-3016(98)00375-7
]Search in Google Scholar
[
19. Onimaru R, Hasegawa M, Yasuda K, Homma A, Oridate N, Fukuda S, et al. Radiotherapy for glottic T1N0 carcinoma with slight hypofractionation and standard overall treatment time: Importance of overall treatment time. JpnJ Clin Oncol 2011; 41: 103-19.10.1093/jjco/hyq153
]Search in Google Scholar
[
20. Duncan W, MacDougall RH, Kerr GR, Downing D. Adverse effect of treatment gaps in the outcome of radiotherapy for laryngeal cancer. RadiotherOncol 1996; 41: 203-7.10.1016/S0167-8140(96)01838-5
]Search in Google Scholar
[
21. Le QT, Fu KK, Kroll S, Ryu JK, Quivey JM, Meyler TS, et al. Influence of fraction size, total dose and overall time on local control of T1-T2 glottic cancinoma. Int J Radiat Oncol Biol Phys 1997; 39: 115-26.10.1016/S0360-3016(97)00284-8
]Search in Google Scholar
[
22. Yu E, Shenouda G, Beaudet MP. Impact of radiation therapy fraction size on local control of early glottis carcinoma. Int J Radiat Oncol Biol Phys 1997; 37: 587-91.10.1016/S0360-3016(96)00578-0
]Search in Google Scholar
[
23. Gowda RV, Henk JM, Mais KL, Sykes AJ, Swindell R, Slevin NJ. Three weeks radiotherapy for T1 glottic cancer: the Christie and Royal Marsden Hospital expperience. Radiother Oncol 2003; 68: 105-11.10.1016/S0167-8140(03)00059-8
]Search in Google Scholar
[
24. Agarwal J, Baccher GK, Waghmare CM, Mallick I, Ghosh-Laskar S, Budrukkar A, et al. Factors affecting the quality of voice in the early glottis cancer treated with radiotherapy. Radiother Oncol 2009; 90: 177-82.10.1016/j.radonc.2008.09.01618937990
]Search in Google Scholar
[
25. Di Nicola L, Gravina GL, Marampon F, Bonfili P, Buonopane S, Di Staso M, et al. The impact of conventional or hypofractionated radiotherapy on voice quality and oncological outcome in patients with early glottic cancer. OncolReports 2010; 24: 1383-8.
]Search in Google Scholar
[
26. Cheah NL, Lupton S, Marshall A, Hartley A, Glaholm J. Outcome of the T1N0M0 squamous cell carcinoma of the larynx treated with short-course radiotherapy to a total dose of 50 Gy in 16 fractions: the Birmingham Experience. Clin Oncol 2009; 21: 494-501.10.1016/j.clon.2009.02.00819375900
]Search in Google Scholar
